A detailed history of Quadrature Capital LTD transactions in Pfizer Inc stock. As of the latest transaction made, Quadrature Capital LTD holds 394,956 shares of PFE stock, worth $10.5 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
394,956
Previous 617,554 36.05%
Holding current value
$10.5 Million
Previous $17.3 Billion 33.89%
% of portfolio
0.26%
Previous 0.29%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $6.17 Million - $6.99 Million
-222,598 Reduced 36.05%
394,956 $11.4 Billion
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $15.6 Million - $18.3 Million
617,554 New
617,554 $17.3 Billion
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.55 Million - $3.11 Million
58,196 New
58,196 $2.55 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $9.5 Million - $11.3 Million
-204,107 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $9.34 Million - $11.6 Million
204,107 New
204,107 $10.6 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $16.9 Million - $25.1 Million
-410,040 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $16.1 Million - $20.7 Million
410,040 New
410,040 $17.6 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $5.49 Million - $6.99 Million
-164,122 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $634,714 - $744,664
-19,991 Reduced 10.86%
164,122 $5.71 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $3.78 Million - $4.29 Million
114,818 Added 165.69%
184,113 $6.84 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $2.26 Million - $2.93 Million
-69,478 Reduced 50.07%
69,295 $2.36 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $4.89 Million - $5.37 Million
130,396 Added 1556.6%
138,773 $0
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $267,310 - $310,116
8,377 New
8,377 $0

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Quadrature Capital LTD Portfolio

Follow Quadrature Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Quadrature Capital LTD with notifications on news.